CASI Pharmaceuticals (CASIF) Return on Equity [ROE] (2023 - 2024)
CASI Pharmaceuticals (CASIF) posted Return on Equity [ROE] of -500.17% for Q4 2024, down 401.00 percentage points from -99.17% a year earlier and down 247.43 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Return on Equity [ROE] (2023 - 2024) Analysis & Trends
For FY2024, CASI Pharmaceuticals' Return on Equity [ROE] came in at -301.80%, down 225.40 percentage points from FY2023.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a three-year change of -258.63 percentage points (FY2021 to FY2024).
- In prior years, CASI Pharmaceuticals' Return on Equity [ROE] was -76.40% in FY2023 (-14.02 pp), -62.38% in FY2022 (-19.20 pp) and -43.17% in FY2021.
- The Q4 2024 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2023.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -174.01 percentage points over the last four quarters.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -252.74% (Q3 2024), -204.93% (Q2 2024) and -151.69% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -500.17% |
| Sep 30, 2024 | -252.74% |
| Jun 30, 2024 | -204.93% |
| Mar 31, 2024 | -151.69% |
| Dec 31, 2023 | -99.17% |
| Sep 30, 2023 | -116.15% |
| Jun 30, 2023 | -108.49% |
| Mar 31, 2023 | -89.69% |
API Access
CASI Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();